Open AccessTherapeutic Options in Myelodysplastic Syndromes Following Hypomethylating Agent Failure
Author(s) -
Abigail Belasen,
Shyamala C. Navada
Publication year - 2020
Publication title -
journal of scientific innovation in medicine
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2579-0153
DOI - 10.29024/jsim.62
Subject(s) - myelodysplastic syndromes , hypomethylating agent , medicine , azacitidine , oncology , intensive care medicine , biology , dna methylation , bone marrow , biochemistry , gene expression , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom